Unsupported browser

For a better experience please update your browser to its latest version.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more


Work has started on Sheppard Robson's £8.2 million centre for research into the causes and treatment of diabetes. The 5,300m 2building is being constructed for the Oxford Radcliffe Hospitals NHS Trust, pharmaceutical company Novo Nordisk and the University of Oxford. It is to consist of a pair of two-storey clinical facilities flanking a triangular atrium.The third side will be enclosed by a three-storey research building. The complex incorporates an energy-saving aerofoil roof.

Already a subscriber? Login here or activate your digital account